GENFIT

GENFIT (EPA:GNFT)

29/04/2022 22:10

GENFIT Announces Publication of the 2021 Universal Registration Document; the 2021 Annual Report on Form 20-F and Availability of Preparatory Documents for the Annual Combined Shareholders Meeting on May 25, 2022

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

20/04/2022 22:10

GENFIT Annual Combined General Meeting of May 25, 2022 — Availability of Preparatory Documents

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

07/04/2022 22:10

GENFIT Reports Full-Year 2021 Financial Results and Provides Corporate Update

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

28/02/2022 22:10

GENFIT Announces Solid Revenues and Cash Position as of December 31, 2021

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

24/01/2022 22:10

GENFIT: 2022 Financial Calendar

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

21/01/2022 22:10

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

18/11/2021 22:15

GENFIT: FNIH NIMBLE Study Demonstrates NIS4® Technology’s Unique Performance in Identifying Patients with “at-risk” NASH

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

09/11/2021 22:10

GENFIT Announces First Patient First Visit for the Evaluation of NTZ in Subjects with Hepatic Impairment as part of its ACLF Program

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

08/11/2021 22:10

GENFIT: Third Quarter 2021 Financial Information

Voir tous les communiqués de GENFIT

GENFIT (EPA:GNFT)

02/11/2021 22:10

New Clinical Data on GENFIT’s Investigational Compound Elafibranor to be Presented at AASLD The Liver Meeting®

Voir tous les communiqués de GENFIT

«
1
2
3
4
5
6
»